Home/Filings/4/0001179110-20-011375
4//SEC Filing

Shafer Bradford J 4

Accession 0001179110-20-011375

CIK 0001583107other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 6:22 PM ET

Size

4.5 KB

Accession

0001179110-20-011375

Insider Transaction Report

Form 4
Period: 2020-11-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2020-11-20$17.21/sh4,807$82,728251,916 total

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001302448

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:22 PM ET
Size
4.5 KB